Michael Harris, chief executive officer of Biocomposites explores the threat of antibiotic resistance and how antibiotics are being used within the orthopaedics industry.
Stuart Madden, chief scientific officer at neuroscience company Neurelis, examines the drug delivery sector and the opportunities non-invasive methods present to the industry and patients.
How drug delivery methods have evolved to deliver complex formulations using multiparticulate technology - with a focus on extrusion-spheronisation coated bead technology.
Dr Tracy Brown, head of Life Sciences and Healthcare at TÜV SÜD National Engineering Laboratory explores the advances being made to reduce medical error with improved infusion drug delivery.
EPM speaks to Lonza to learn about how to ensure good bioavailability across compounds and which therapy areas are benefitting from targeted drug delivery.
George I’ons - head of Product Strategy and Insights at Owen Mumford Pharmaceutical Services takes a deep dive into the state of the connected drug delivery device industry.
